Campylobacter infections in HIV-infected patients: clinical and bacteriological features.

Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Campylobacter infections in HIV-infected patients: clinical and bacteriological features.

AIDS. 1995 Aug;9(8):881-5. Unique Identifier : AIDSLINE MED/96014961
Molina J; Casin I; Hausfater P; Giretti E; Welker Y; Decazes J; Garrait V; Lagrange P; Modai J; Infectious Disease Department, Saint-Louis Hospital, Paris,; France.

Abstract: OBJECTIVE: To study the clinical and bacteriological features of Campylobacter infections in HIV-infected patients. DESIGN: A retrospective analysis (1989-1992), followed by a prospective analysis (1992-1994). SETTING: Hospital HIV inpatient unit. PATIENTS AND METHODS: All patients with Campylobacter spp. identified by the laboratory of microbiology at Saint-Louis Hospital, Paris were studied, and their clinical features as well as their response to therapy recorded. RESULTS: During the study period, Campylobacter infection was documented in 38 HIV-infected patients, 76% of whom had AIDS. Campylobacter spp. was isolated from stools in 36 cases and from blood cultures in four cases. Species identification yielded C. jejuni (84%) and C. coli (16%). High-level resistance to quinolones was frequently observed (21%), but resistance to erythromycin (3%) and tetracycline (5%) was rare. Diarrhoea, fever and abdominal pain were the main clinical features of infection. Other intestinal pathogens were found in 42% of patients. Most patients had an acute illness with rapid resolution under appropriate antimicrobial therapy. However, eight patients (21%), experienced chronic diarrhoea with persistent isolation of Campylobacter and in vivo selection of resistant strains, requiring multiple courses of antibiotics. CONCLUSIONS: Campylobacter usually cause acute diarrhoea in patients with HIV infection. Antimicrobial therapy should be guided on in vitro susceptibility testing because of the prevalence of antibiotic resistance. Despite appropriate therapy, some patients will present with prolonged diarrhoea and in vivo selection of multiresistant isolates.

Keywords: Adult Antibiotics/THERAPEUTIC USE AIDS-Related Opportunistic Infections/*DIAGNOSIS/DRUG THERAPY/ MICROBIOLOGY *Campylobacter coli/DRUG EFFECTS/ISOLATION & PURIF *Campylobacter jejuni/DRUG EFFECTS/ISOLATION & PURIF Case Report Diarrhea/COMPLICATIONS/DRUG THERAPY/MICROBIOLOGY Drug Resistance, Microbial Feces/VIROLOGY Female Human Male Middle Age Prospective Studies Retrospective Studies Support, Non-U.S. Gov't JOURNAL ARTICLE
960228
M9621068

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .